5V7I | Transferase Transferase Inhibitor | date | Mar 20, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Homo Sapiens Serine Hydroxymethyltransf (Mitochondrial) (Shmt2), In Complex With Glycine, Plp And F Competitive Pyrazolopyran Inhibitor: 6-Amino-4-Isopropyl-3- (3-(Pyrrolidin-1-Yl)-5-(Trifluoromethyl)Phenyl)-1,4-Dihydro 3-C]Pyrazole-5-Carbonitrile | ||||||||||||||
authors | G.S.Ducker, J.M.Ghergurovich, N.Mainolfi, V.Suri, S.Jeong, A.Frie M.Manfredi, H.Kim, J.D.Rabinowitz | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Serine Hydroxymethyltransferase, Mitochondrial Chain: A, B Synonym: Shmt,Glycine Hydroxymethyltransferase,Serine Methy Ec: 2.1.2.1 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Shmt2 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 65 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.47 Å | ||||||||||||
ligand | 8Z1, GLY, GOL, LLP, PEG | enzyme | Transferase E.C.2.1.2.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma., Ducker GS, Ghergurovich JM, Mainolfi N, Suri V, Jeong SK, Hsin-Jung Li S, Friedman A, Manfredi MG, Gitai Z, Kim H, Rabinowitz JD, Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11404-11409. doi:, 10.1073/pnas.1706617114. Epub 2017 Oct 9. PMID:29073064 |
Data retrieval |
View 5V7I in 3D |
Visual 3D analysis of 5V7I |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5V7I |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |